Literature DB >> 10188986

Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.

X P Huang1, P I Nagy, F E Williams, S M Peseckis, W S Messer.   

Abstract

Conserved amino acids, such as Thr in transmembrane domains (TM) V and Asn in TM VI of muscarinic receptors, may be important in agonist binding and/or receptor activation. In order to determine the functional roles of Thr192 and Asn382 in human M1 receptors in ligand binding and receptor activation processes, we created and characterized mutant receptors with Thr192 or Asn382 substituted by Ala. HM1 wild-type (WT) and mutant receptors [HM1(Thr192Ala) and HM1(Asn382Ala)] were stably expressed in A9 L cells. The Kd values for 3H-(R)-QNB and Ki values for other classical muscarinic antagonists were similar at HM1(WT) and HM1(Thr192Ala) mutant receptors, yet higher at HM1(Asn382Ala) mutant receptors. Carbachol exhibited lower potency and efficacy in stimulating PI hydrolysis via HM1(Thr192Ala) mutant receptors, and intermediate agonist activity at the HM1(Asn382Ala) mutant receptors. The Asn382 residue in TM VI but not the Thr192 residue in TM V of the human M1 receptor appears to participate directly in antagonist binding. Both Thr192 and Asn382 residues are involved differentially in agonist binding and/or receptor activation processes, yet the Asn382 residue is less important than Thr192 in agonist activation of M1 receptors. Molecular modelling studies indicate that substitution of Thr192 or Asn382 results in the loss of hydrogen-bond interactions and changes in the agonist binding mode associated with an increase in hydrophobic interactions between ligand and receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188986      PMCID: PMC1565834          DOI: 10.1038/sj.bjp.0702301

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Biochemical and behavioral responses of pilocarpine at muscarinic receptor subtypes in the CNS. Comparison with receptor binding and low-energy conformations.

Authors:  W Hoss; J M Woodruff; B R Ellerbrock; S Periyasamy; S Ghodsi-Hovsepian; J Stibbe; M Bohnett; W S Messer
Journal:  Brain Res       Date:  1990-11-19       Impact factor: 3.252

Review 2.  Muscarinic receptor subtypes.

Authors:  E C Hulme; N J Birdsall; N J Buckley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1990       Impact factor: 13.820

3.  Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system.

Authors:  M R Tota; M I Schimerlik
Journal:  Mol Pharmacol       Date:  1990-06       Impact factor: 4.436

4.  Expression of a cloned muscarinic receptor in A9 L cells.

Authors:  M R Brann; N J Buckley; S V Jones; T I Bonner
Journal:  Mol Pharmacol       Date:  1987-10       Impact factor: 4.436

5.  A rapid separation method for inositol phosphates and their isomers.

Authors:  K A Wreggett; R F Irvine
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function.

Authors:  C M Fraser; C D Wang; D A Robinson; J D Gocayne; J C Venter
Journal:  Mol Pharmacol       Date:  1989-12       Impact factor: 4.436

8.  Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; A C Young; M R Brann; N J Buckley
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

9.  Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.

Authors:  J S Ward; L Merritt; V J Klimkowski; M L Lamb; C H Mitch; F P Bymaster; B Sawyer; H E Shannon; P H Olesen; T Honoré
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  7 in total

1.  Distinct profiles of functional discrimination among G proteins determine the actions of G protein-coupled receptors.

Authors:  Ikuo Masuho; Olga Ostrovskaya; Grant M Kramer; Christopher D Jones; Keqiang Xie; Kirill A Martemyanov
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

2.  Theoretical and experimental studies of the isomeric protonation in solution for a prototype aliphatic ring containing two nitrogens.

Authors:  Peter I Nagy; Aditya Maheshwari; Yong-Wah Kim; William S Messer
Journal:  J Phys Chem B       Date:  2010-01-14       Impact factor: 2.991

3.  Comparison on functional assays for Gq-coupled GPCRs by measuring inositol monophospate-1 and intracellular calcium in 1536-well plate format.

Authors:  Ke Liu; Steve Titus; Noel Southall; Pingjun Zhu; James Inglese; Christopher P Austin; Wei Zheng
Journal:  Curr Chem Genomics       Date:  2008-07-11

4.  Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.

Authors:  Thibault Varin; Hugo Gutiérrez-de-Terán; Marián Castro; José Brea; Frederic Fabis; François Dauphin; Johan Aqvist; Alban Lepailleur; Pilar Perez; Javier Burgueño; José Miguel Vela; Maria Isabel Loza; Jordi Rodrigo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

5.  In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri.

Authors:  Seetha Ramasamy; Sek Peng Chin; Sri Devi Sukumaran; Michael James Christopher Buckle; Lik Voon Kiew; Lip Yong Chung
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 6.  Placental protein 13: An important biological protein in preeclampsia.

Authors:  Ranjeeta Gadde; Dayanand Cd; S R Sheela
Journal:  J Circ Biomark       Date:  2018-07-15

7.  Design, Synthesis, and Biological Evaluation of 4,4'-Difluorobenzhydrol Carbamates as Selective M1 Antagonists.

Authors:  Jonas Kilian; Marius Ozenil; Marlon Millard; Dorka Fürtös; Verena Maisetschläger; Wolfgang Holzer; Wolfgang Wadsak; Marcus Hacker; Thierry Langer; Verena Pichler
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.